Skip to main content

Geriatric Assessment

0
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Geriatric Pain Measurement Short FormN/A1 trial
Active Trials
NCT06877481RecruitingEst. Jun 2025
Bristol Myers Squibb
1 program
Practical Geriatric AssessmentN/A1 trial
Active Trials
NCT06870617Recruiting150Est. Oct 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Bristol Myers SquibbPractical Geriatric Assessment
City TherapeuticsGeriatric Pain Measurement Short Form

Clinical Trials (2)

Total enrollment: 150 patients across 2 trials

NCT06870617Bristol Myers SquibbPractical Geriatric Assessment

Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)

Start: Jul 2025Est. completion: Oct 2026150 patients
N/ARecruiting
NCT06877481City TherapeuticsGeriatric Pain Measurement Short Form

Turkish Validation of the Geriatric Pain Measure - Short Form

Start: Mar 2025Est. completion: Jun 2025
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 150 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.